Bal Pharma Limited (BOM:524824)
India · Delayed Price · Currency is INR 107.47
+1.12 (1.05%)
At close: Sep 11, 2026
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.71 billion as of September 11, 2026. Its market cap has increased by 21.44% in one year.
Market Cap
1.71B
Enterprise Value
3.21B
Revenue
3.34B
Ranking
n/a
PE Ratio
23.87
Stock Price
107.47
ChartMarket Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.71B, an increase of 205.57%. That is a compound annual growth rate of 5.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.71B | 46.72% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kerala Ayurveda | 2.24B |
| Sanjivani Paranteral | 2.22B |
| Bilcare | 2.20B |
| Sat Kartar Life | 2.07B |
| Bio Medica Laboratories | 2.01B |
| Coral Laboratories | 2.01B |
| Oxygenta Pharmaceutical | 1.99B |
| Parnax Lab | 1.51B |